MECOTEC

MECOTEC

MECOTEC operates from Germany as a specialist manufacturer of electric whole-body cryotherapy chambers. Its technology is built around convection-based cooling that circulates chilled ambient air, a departure from the liquid-nitrogen systems that dominate the market. The firm targets the intersection of sports medicine, luxury wellness, and preventive health, supplying standalone cryo cabins and hybrid sauna-cryo units to destinations that range from professional football clubs to five-star thermal spas. The company's product line centers on the cryo:one chamber and the cryo:air hybrid cabin, both designed to achieve therapeutic cold exposure without direct contact with cryogenic gases. Target temperatures reach approximately -110°C at the air outlet, with cabin air around -85°C—sufficient to trigger the vasoconstriction and cold-shock protein response that practitioners claim reduces inflammation and accelerates muscle recovery. End users include elite sports organizations across the Bundesliga, Premier League, and Formula 1, as well as hospitality operators who treat cryotherapy as a spa-menu differentiator. MECOTEC competes with liquid-nitrogen incumbents Art of Cryo and Zimmer MedizinSysteme, positioning its electric platform as a safety-first alternative that eliminates the asphyxiation and burn risks of stored liquid nitrogen. As a privately held German manufacturer, MECOTEC does not disclose revenues, unit sales, or installed-base figures. Evidence of operational activity surfaces through its client roster rather than financial disclosure: the firm has delivered units globally, with reports of installations at destinations including Lux* Resorts in Mauritius and the CryoLab franchise network in Australia. Its distribution model pairs direct sales to large institutional clients with a network of third-party wellness distributors in Europe, the Middle East, and Asia-Pacific. Without published headcount data, MECOTEC fits the profile of a niche technical OEM—a business where engineering and regulatory compliance likely dominate headcount over marketing or finance. MECOTEC's structural distinction is its choice to fight the cryotherapy market from the hardware layer rather than the franchise or operating-company model that competitors have pursued. Where chains like US Cryotherapy build consumer-facing clinic networks with leased equipment, MECOTEC remains a pure equipment manufacturer—revenues come from chamber sales and service contracts, not recurring patient visits. This makes the company a pick-and-shovel supplier to the wellness trend, insulated from the unit-level economics that determine whether a standalone cryo clinic survives, but also dependent on a steady pipeline of new spa and sports-facility construction to sustain its order book.